Cumulative Burden of Colorectal Cancer-Associated Genetic Variants is More Strongly Associated With Early-onset vs Late-onset Cancer.

BACKGROUND & AIMS Early-onset colorectal cancer (CRC, in persons younger than 50 years old) is increasing in incidence; yet, in the absence of a family history of CRC, this population lacks harmonized recommendations for prevention. We aimed to determine whether a polygenic risk score (PRS) developed from 95 CRC-associated common genetic risk variants was associated with risk for early-onset CRC. METHODS We studied risk for CRC associated with a weighted PRS in 12,197 participants younger than 50 years old vs 95,865 participants 50 years or older. PRS was calculated based on single-nucleotide polymorphisms associated with CRC in a large-scale genome-wide association study as of January 2019. Participants were pooled from 3 large consortia that provided clinical and genotyping data: the Colon Cancer Family Registry, the Colorectal Transdisciplinary study, and the Genetics and Epidemiology of Colorectal Cancer Consortium and were all of genetically defined European descent. Findings were replicated in an independent cohort of 72,573 participants. RESULTS Overall associations with CRC per standard deviation of PRS were significant for early-onset cancer, and were stronger compared with late-onset cancer (P for interaction=.01); when we compared the highest PRS quartile with the lowest, risk increased 3.7-fold for early-onset CRC (95% CI, 3.28-4.24) vs 2.9-fold for late-onset CRC (95% CI, 2.80-3.04). This association was strongest for participants without a first-degree family history of CRC (P for interaction=5.61x10-5). When we compared the highest with the lowest quartiles in this group, risk increased 4.3-fold for early-onset CRC (95% CI, 3.61-5.01) vs 2.9-fold for late-onset CRC (95% CI, 2.70-3.00). Sensitivity analyses were consistent with these findings. CONCLUSIONS In an analysis of associations with CRC per standard deviation of PRS, we found the cumulative burden of CRC-associated common genetic variants to associate with early-onset cancer, and to be more strongly associated with early-onset than late-onset cancer-particularly in the absence of CRC family history. Analyses of PRS, along with environmental and lifestyle risk factors, might identify younger individuals who would benefit from preventative measures.

Stephanie A. Bien | Elizabeth L. Barry | Aung Ko Win | T. Hudson | C. Ulrich | E. Feskens | D. English | H. Brenner | J. Chang-Claude | M. Hoffmeister | R. Hayes | S. Chanock | J. Potter | D. Hunter | D. Seminara | A. Zauber | S. Gruber | D. Duggan | S. Larsson | A. Wolk | M. Woods | G. Giles | G. Severi | J. Hopper | C. Haiman | S. Thibodeau | M. Southey | L. FitzGerald | A. Joshi | D. Easton | P. Goodman | C. Tangen | J. Hampe | G. Rennert | P. Pharoah | K. Offit | D. Conti | L. Le Marchand | D. Albanes | S. Weinstein | F. Schumacher | L. Wilkens | S. Berndt | R. Milne | V. Moreno | G. Casey | S. Markowitz | E. Platz | J. Baron | A. Trichopoulou | A. Lindblom | S. Gallinger | A. Toland | A. Wu | P. Newcomb | U. Peters | R. Sandler | M. Jenkins | I. Lansdorp-Vogelaar | H. Lenz | L. Hsu | E. Jacobs | S. Männistö | E. White | P. Parfrey | R. Schoen | M. Gunter | N. Murphy | D. Palli | M. Slattery | M. Du | S. Küry | N. Lindor | M. Cotterchio | A. Zeleniuch‐Jacquotte | D. Corley | J. Huyghe | D. Bishop | D. Buchanan | E. Siegel | E. Barry | K. Weigl | Yin Cao | A. Cross | J. Figueiredo | A. Chapelle | E. Kampman | S. Buch | C. Schafmayer | C. Edlund | C. Joshu | Yi Lin | P. Vodicka | T. Harrison | H. Hampel | L. Moreira | M. Song | T. Keku | L. Sakoda | F. Elliott | S. Bézieau | P. Campbell | A. Gsur | T. Kühn | H. Rennert | R. MacInnis | Christopher I. Li | M. Gago-Domínguez | J. Castelao | K. Visvanathan | B. Younghusband | M. Chirlaque | A. Burnett-Hartman | María-José Sánchez | Elisabeth F P Peterse | V. Munoz-Garzon | F. V. van Duijnhoven | S. Castellví-Bel | Li Li | B. van Guelpen | C. Mancao | R. Pearlman | Minta Thomas | A. Holowatyj | V. Martín | Stephanie L. Schmit | J. Jeon | S. Brezina | S. Harlid | Wen-Yi Huang | L. Vodickova | Peter S. Liang | A. Chan | S. Bien | J. E. Castelao | M. Sánchez | A. Archambault | Yu-Ru Su | S. Schmit | Jihyoun Jeon | Yu-Ru Su | Yu-Ru Su | M. Jenkins | Mengmeng Du | D. Hunter | D. Bishop | A. Wu | Sophia Harlid | L. Hsu

[1]  A. Jemal,et al.  Global patterns and trends in colorectal cancer incidence in young adults , 2019, Gut.

[2]  Stephanie A. Bien,et al.  Novel Common Genetic Susceptibility Loci for Colorectal Cancer , 2018, Journal of the National Cancer Institute.

[3]  Colorectal Cancer Screening in Average-Risk Adults , 2019, Annals of Internal Medicine.

[4]  M. Jenkins,et al.  Trends in Colon and Rectal Cancer Incidence in Australia from 1982 to 2014: Analysis of Data on Over 375,000 Cases , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[5]  J. Baron,et al.  Decrease in Incidence of Young-Onset Colorectal Cancer Before Recent Increase. , 2018, Gastroenterology.

[6]  Mathieu Lemire,et al.  Discovery of common and rare genetic risk variants for colorectal cancer , 2018, Nature Genetics.

[7]  U. Ladabaum,et al.  Potential Intended and Unintended Consequences of Recommending Initiation of Colorectal Cancer Screening at Age 45 Years. , 2018, Gastroenterology.

[8]  D. Corley,et al.  When Should Guidelines Change? A Clarion Call for Evidence Regarding the Benefits and Risks of Screening for Colorectal Cancer at Earlier Ages. , 2018, Gastroenterology.

[9]  Stephanie A. Bien,et al.  Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors. , 2018, Gastroenterology.

[10]  C. Flowers,et al.  Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society , 2018, CA: a cancer journal for clinicians.

[11]  D. Brenner,et al.  Increasing colorectal cancer incidence trends among younger adults in Canada. , 2017, Preventive medicine.

[12]  R. Yantiss,et al.  Early‐onset Colorectal Cancer is Distinct From Traditional Colorectal Cancer , 2017, Clinical colorectal cancer.

[13]  J. Baron,et al.  RE: Colorectal Cancer Incidence Patterns in the United States, 1974-2013. , 2017, Journal of the National Cancer Institute.

[14]  David Lieberman,et al.  Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer. , 2017, Gastroenterology.

[15]  P. Goodfellow,et al.  Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer , 2017, JAMA oncology.

[16]  J. Park,et al.  Common risk variants for colorectal cancer: an evaluation of associations with age at cancer onset , 2017, Scientific Reports.

[17]  Karen M Kuntz,et al.  Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. , 2016, JAMA.

[18]  M. Phipps,et al.  Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.

[19]  Aung Ko Win,et al.  Quantifying the utility of single nucleotide polymorphisms to guide colorectal cancer screening. , 2016, Future oncology.

[20]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[21]  A. Hoischen,et al.  Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer , 2015, Scientific Reports.

[22]  Christopher P. Fischer,et al.  Genome-wide association study of colorectal cancer identifies six new susceptibility loci , 2015, Nature Communications.

[23]  Teresa A. Webster,et al.  Genotyping Informatics and Quality Control for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort , 2015, Genetics.

[24]  C. Sabatti,et al.  Characterizing Race/Ethnicity and Genetic Ancestry for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort , 2015, Genetics.

[25]  Mengmeng Du,et al.  A model to determine colorectal cancer risk using common genetic susceptibility loci. , 2015, Gastroenterology.

[26]  S. Cantor,et al.  Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. , 2015, JAMA surgery.

[27]  John D Potter,et al.  Estimating the heritability of colorectal cancer. , 2014, Human molecular genetics.

[28]  J. Hopper,et al.  Deciphering the genetic architecture of low-penetrance susceptibility to colorectal cancer. , 2013, Human molecular genetics.

[29]  Simon G. Coetzee,et al.  Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. , 2013, Gastroenterology.

[30]  지선하 Identification of genetic susceptibility loci for colorectal tumors in a genome-wide meta-analysis , 2013 .

[31]  Peter Kraft,et al.  Heritability in the genome-wide association era , 2012, Human Genetics.

[32]  S. Ballereau,et al.  Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals , 2012, Gut.

[33]  V. Moreno,et al.  Susceptibility genetic variants associated with early-onset colorectal cancer. , 2012, Carcinogenesis.

[34]  Simon Cawley,et al.  Next generation genome-wide association tool: design and coverage of a high-throughput European-optimized SNP array. , 2011, Genomics.

[35]  Naomi R. Wray,et al.  Synthetic Associations Created by Rare Variants Do Not Explain Most GWAS Results , 2011, PLoS biology.

[36]  B. Henderson,et al.  Generalizability and Epidemiologic Characterization of Eleven Colorectal Cancer GWAS Hits in Multiple Populations , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[37]  L. Påhlman,et al.  Association studies on 11 published colorectal cancer risk loci , 2010, British Journal of Cancer.

[38]  T. Tuohy,et al.  Hereditary and familial colon cancer. , 2010, Gastroenterology.

[39]  J. Houwing-Duistermaat,et al.  Enrichment of Low Penetrance Susceptibility Loci in a Dutch Familial Colorectal Cancer Cohort , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[40]  D. Ransohoff,et al.  Adverse Events After Outpatient Colonoscopy in the Medicare Population , 2009, Annals of Internal Medicine.

[41]  A. Jemal,et al.  Increase in Incidence of Colorectal Cancer Among Young Men and Women in the United States , 2009, Cancer Epidemiology Biomarkers & Prevention.

[42]  Heather Hampel,et al.  Feasibility of screening for Lynch syndrome among patients with colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  Bernadette Mazurek Melnyk,et al.  Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.

[44]  R. Prentice,et al.  Bias-reduced estimators and confidence intervals for odds ratios in genome-wide association studies. , 2008, Biostatistics.

[45]  Karla Kerlikowske,et al.  Trends in Colonoscopy for Colorectal Cancer Screening , 2007, Medical care.

[46]  M. Goodman,et al.  Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992–2001 , 2006, Cancer.

[47]  C. Lopes,et al.  MSH6 germline mutations in early-onset colorectal cancer patients without family history of the disease , 2006, British Journal of Cancer.

[48]  W. Frankel,et al.  Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). , 2005, The New England journal of medicine.

[49]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.